Bulunamayan Paratiroid Adenomlarında Radyolojik Görüntüleme ve Cerrahi Yaklaşım

Berber E, Parikh RT, Ballem N, et al. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery. 2008 Jul;144(1):74-9. doi: 10.1016/j.surg.2008.03.019.
Terris DJ, Stack BC Jr, Gourin CG. Contemporary parathyroidectomy: exploiting technology. Am J Otolaryngol. 2007 Nov-Dec;28(6):408-14. doi: 10.1016/j.amjoto.2006.10.013.
Catalfamo A, Famà F, Pergolizzi FP, et al. Management of undetectable and lost parathyroid adenoma. Ann Thyroid. 2018;3:1–1.
Vitetta GM, Neri P, Chiecchio A, et al. Role of ultrasonography in the management of patients with primary hyperparathyroidism: retrospective comparison with technetium-99m sestamibi scintigraphy. J Ultrasound. 2014 Jan 31;17(1):1-12. doi: 10.1007/s40477-014-0067-8.
Rampp RD, Mancilla EE, Adzick NS, et al. Single Gland, Ectopic Location: Adenomas are Common Causes of Primary Hyperparathyroidism in Children and Adolescents. World J Surg. 2020 May;44(5):1518-1525. doi: 10.1007/s00268-019-05362-8.
Sung JY. Parathyroid ultrasonography: the evolving role of the radiologist. Ultrasonography. 2015 Oct;34(4):268-74. doi: 10.14366/usg.14071.
Tay D, Das JP, Yeh R. Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review. Biomedicines. 2021 Apr 6;9(4):390. doi: 10.3390/biomedicines9040390.
Mahajan A, Starker LF, Ghita M, et al. Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism. World J Surg. 2012 Jun;36(6):1335-9. doi: 10.1007/s00268-011-1365-3.
Nael K, Hur J, Bauer A, et al. Dynamic 4D MRI for Characterization of Parathyroid Adenomas: Multiparametric Analysis. AJNR Am J Neuroradiol. 2015 Nov;36(11):2147-52. doi: 10.3174/ajnr.A4425.
Becker JL, Patel V, Johnson KJ, et al. 4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism. AJNR Am J Neuroradiol. 2020 Mar;41(3):522-528. doi: 10.3174/ajnr.A6482.
Lee JY, Song HS, Choi JH, et al. Detecting Synchronous Thyroid Adenoma and False-Positive Findings on Technetium-99m MIBI Single Photon-Emission Computed Tomography/Computed Tomography. Diagnostics (Basel). 2019 Jun 1;9(2):57. doi: 10.3390/diagnostics9020057.
Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism: a function of operative approach? Arch Surg. 2002 Aug;137(8):896-9; discussion 899-900. doi: 10.1001/archsurg.137.8.896.
Dy BM, Richards ML, Vazquez BJ, et al. Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol. 2012 Jul;19(7):2272-8. doi: 10.1245/s10434-012-2325-3.
Acar N, Haciyanli M, Coskun M, et al. Diagnostic value of four-dimensional computed tomography and four-dimensional magnetic resonance imaging in primary hyperparathyroidism when first-line imaging was inadequate. Ann R Coll Surg Engl. 2020 Apr;102(4):294-299. doi: 10.1308/rcsann.2019.0182.
Giovanella L, Bacigalupo L, Treglia G, et al. Will 18F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging? Endocrine. 2021 Feb;71(2):285-297. doi: 10.1007/s12020-020-02487-y.
Abdelghani R, Noureldine S, Abbas A, et al. The diagnostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperparathyroidism. Laryngoscope. 2013 May;123(5):1310-3. doi: 10.1002/lary.23863.
Stack BC Jr, Tolley NS, Bartel TB, et al. AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons. Head Neck. 2018 Aug;40(8):1617-1629. doi: 10.1002/hed.25023.
Turgut B, Elagoz S, Erselcan T, et al. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume. Cancer Biother Radiopharm. 2006 Dec;21(6):579-90. doi: 10.1089/cbr.2006.21.579.
Neumann DR, Esselstyn CB, Maclntyre WJ, et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med. 1996 Nov;37(11):1809-15.
Beheshti M, Hehenwarter L, Paymani Z, et al. 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1762-1771. doi: 10.1007/s00259-018-3980-9.
Huber GF, Hüllner M, Schmid C, et al. Benefit of 18F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol. 2018 Jun;28(6):2700-2707. doi: 10.1007/s00330-017-5190-4.
Araz M, Soydal Ç, Özkan E, et al. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nucl Med Commun. 2018 Nov;39(11):989-994. doi: 10.1097/MNM.0000000000000899.
Uslu-Beşli L, Sonmezoglu K, Teksoz S, et al. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging. Korean J Radiol. 2020 Feb;21(2):236-247. doi: 10.3348/kjr.2019.0268.
Lalire P, Ly S, Deguelte S, et al. Incremental Value of 18F-Fluorocholine PET/CT in the Localization of Double Parathyroid Adenomas. Clin Nucl Med. 2017 Mar;42(3):218-220. doi: 10.1097/RLU.0000000000001500.
Kluijfhout WP, Pasternak JD, Gosnell JE, et al. 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study. Radiology. 2017 Aug;284(2):460-467. doi: 10.1148/radiol.2016160768.
Elaraj D, Sturgeon C. Operative treatment of primary hyperparathyroidism: balancing cost-effectiveness with successful outcomes. Surg Clin North Am. 2014 Jun;94(3):607-23. doi: 10.1016/j.suc.2014.02.011.
Wei B, Inabnet W, Lee JA, et al. Optimizing the minimally invasive approach to mediastinal parathyroid adenomas. Ann Thorac Surg. 2011 Sep;92(3):1012-7. doi: 10.1016/j.athoracsur.2011.04.091.
Silberfein EJ, Bao R, Lopez A, et al. Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. Arch Surg. 2010 Nov;145(11):1065-8. doi: 10.1001/archsurg.2010.230.
Levin KE, Clark OH. The reasons for failure in parathyroid operations. Arch Surg. 1989 Aug;124(8):911-4; discussion 914-5. doi: 10.1001/archsurg.1989.01410080041006.
Shin JJ, Milas M, Mitchell J, et al. Impact of localization studies and clinical scenario in patients with hyperparathyroidism being evaluated for reoperative neck surgery. Arch Surg. 2011 Dec;146(12):1397-403. doi: 10.1001/archsurg.2011.837.
Wojtczak B, Syrycka J, Kaliszewski K, et al. Surgical implications of recent modalities for parathyroid imaging. Gland Surg. 2020 Feb;9(Suppl 2):S86-S94. doi: 10.21037/gs.2019.11.10.
Ilahi A, Muco E, Ilahi TB. Anatomy, Head and Neck, Parathyroid. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537203/
Rosen RD, Bordoni B. Embryology, Parathyroid. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554580/
Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011 Oct;96(10):2950-8. doi: 10.1210/jc.2011-1010.
Machado NN, Wilhelm SM. Parathyroid Cancer: A Review. Cancers (Basel). 2019 Oct 28;11(11):1676. doi: 10.3390/cancers11111676.